发明名称 Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
摘要 The present invention provides MDM2 inhibitor compounds of Formula I or II, or the pharmaceutically acceptable salts thereof,; wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
申请公布号 US9376425(B2) 申请公布日期 2016.06.28
申请号 US201214347628 申请日期 2012.09.26
申请人 Amgen, Inc. 发明人 Bartberger Michael D.;Beck Hilary Plake;Chen Xiaoqi;Connors Richard Victor;Deignan Jeffrey;Duquette Jason A.;Eksterowicz John;Fox Brian M.;Fu Jiasheng;Gonzalez Buenrostro Ana;Gonzalez Lopez De Turiso Felix;Gustin Darin J.;Heath Julie A.;Johnson Michael G.;Kayser Frank;Kopecky David John;Li Yihong;Li Zhihong;Ma Zhihua;McIntosh Joel;Medina Julio C.;Mihalic Jeffrey Thomas;Olson Steven H.;Rew Yosup;Roveto Philip M.;Schmitt Michael J.;Sun Daqing;Wang Xiaodong;Wanska Malgorzata;Weathers Christine;Yan Xuelei
分类号 C07D265/06;C07D413/04;C07D413/10;C07D417/04;C07D413/12;C07D265/32 主分类号 C07D265/06
代理机构 代理人 Bergauer Markus;Lemoine Elsa D.
主权项 1. A compound of Formula I or II, or a pharmaceutically acceptable salt thereof,wherein: Q is O; Z is —C(═O)—; R1 is a phenyl group, and the phenyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —OH, —NO2, —NHC(═O)C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, —(CH2)nC(═O)Rf, —(CH2)nC(═O)NRfRf, —CN, —NRgRg or A, each A is independently a 5 or 6 membered aryl or heteroaryl group, which heteroaryl group can contain from one to three heteroatoms independently selected from O, N or S, and the aryl or heteroaryl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; R2 is a phenyl group, and the phenyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —OH, —NO2, —NHC(═O)C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, —(CH2)nC(═O)Rf, —(CH2)nC(═O)NRfRf, —CN, —NRgRg or B, each B is independently a 5 or 6 membered aryl or heteroaryl group, which heteroaryl group can contain from one to three heteroatoms independently selected from O, N or S, and the aryl or heteroaryl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; R2a is hydrogen or —C1-3alkyl; R3 is hydrogen, —C1-6alkyl, —C(═O)ORf, —C(═O)C1-6alkyl, —S(═O)2Rf, —S(═O)Rf, —ORf, —C(═O)NRfN(Rf)2, —C(═O)NRfS(═O)2Rf, —S(═O)2NRfC(═O)Rf, —S(═O)2NRfRf, —N(Rf)C(═O)NRfRf, —NRfCO2Rf, —C(═O)NRfRf, —NRfS(═O)2Rf, —CN, —NRfRf, —C(═O)NOH, —NRfC(═O)ORf, —NRfC(═O)Rf, —C1-6alkyl substituted with from 1 to 3 hydroyl groups, —C1-6alkenyl, or a 5 or 6 membered aryl or heteroaryl group, which heteroaryl group can contain from one to four heteroatoms independently selected from O, N or S, and the aryl or heteroaryl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN, and any C1-6alkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —OH, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; R4 is —C2-6alkenyl, —CF3, —CH2F, —CHF2, —S(═O)2Rf, —SRf, —S(═O)Rf, —S(═O)2NRfRf, —NRfS(═O)2NRfRf, —C(═O)NRfRf, —NRfS(═O)2Rf, —CO2Rf, —ORf, a 3 to 7 membered cycloalkyl or heterocycloalkyl, optionally containing a —(C═O)— group, or a 5 to 6 membered aryl or heteroaryl group, which heterocycloalkyl or heteroaryl group can contain from one to three heteroatoms independently selected from O, N or S, and the cycloalkyl, heterocycloalkyl, aryl or heteroaryl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl —OH, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN, and the —C1-6alkyl or —C2-6alkenyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —NRfRf, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; R5 is hydrogen or —C1-6alkyl; R6 is hydrogen, —C1-6alkyl, —(CH2)n—NRfRf, or —(CH2)nC(═O)NRfRf; each Ra is independently hydrogen, halo or —C1-6alkyl, or two Ra groups that are attached to the same carbon atom can form an (═O) group or a 3 to 6 membered cycloalkyl or heterocycloalkyl group, or an Ra group and R6 along with the atoms to which they are attached can form a 3 to 6 membered cycloalkyl or heterocycloalkyl group, which heterocycloalkyl group can contain from one to two heteroatoms independently selected from O, N or S, and the cycloalkyl or heterocycloalkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; each Rc is independently hydrogen, —C1-6alkyl, —C1-6alkyl-CF3, —CF3, a 3 to 6 membered cycloalkyl or heterocycloalkyl group, which heterocycloalkyl group can contain from one to two heteroatoms independently selected from O, N or S, and the cycloalkyl or heterocycloalkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; or two Rc groups that are attached to the same or adjacent carbon atoms can together with the carbon atom or atoms to which they are attached form or a 3 to 6 membered cycloalkyl or heterocycloalkyl group, which heterocycloalkyl group can contain from one to two heteroatoms independently selected from O, N or S, and the cycloalkyl or heterocycloalkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; each Rd is independently hydrogen or —C1-6alkyl; each Re is independently hydrogen or —C1-6alkyl; each Rf is independently hydrogen, —CN, —C1-6alkyl, —C1-6alkyl-CN, —C1-6alkyl-CF3, hydroxyC1-6alkyl, —C1-6alkylNReRe, or a 5 to 6 membered aryl, —C1-6alkylaryl, heteroaryl, or —C1-6alkylheteroaryl, or a 3 to 9 membered cycloalkyl, —C1-6alkylcycloalkyl, heterocycloalkyl or —C1-6alkylheterocycloalkyl group, which heteroaryl, alkylheteroaryl, heterocycloalkyl, or alkylheterocycloalkyl group can contain from one to three heteroatoms independently selected from O, N or S, and the alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, cycloalkyl, alkylcycloalkyl, heterocycloalkyl, or alkylheterocycloalkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; or when Rf and Rf are part of an NRfRf or CRfRf moiety in a group, then Rf and Rf together with the nitrogen or carbon atom to which they are attached can form a 3 to 7 membered heterocycloalkyl or cycloalkyl group, which heterocycloalkyl group can contain from one to two additional heteroatoms independently selected from O, N or S, and the heterocycloalkyl or cycloalkyl group can be unsubstituted or substituted with from one to three substituents independently selected from halo, —C1-6alkyl, —S(═O)2C1-6alkyl, —S(═O)C1-6alkyl, —OC1-6alkyl, —CF3, —OCF3, —OCHF2, —OCH2F, or —CN; each Rg is independently hydrogen, or —C1-6alkyl; and each n is independently 0, 1, 2, 3 or 4, provided that the compound is not 2-((2R,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((1S,2S)-2-(isopropylsulfonyl)cyclopentyl)-3-oxomorpholin-2-yl)acetic acid; 2-((2S,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((1S,2S)-2-(isopropylsulfonyl)cyclopentyl)-3-oxomorpholin-2-yl)acetic acid; 2-((2R,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((1R,2R)-2-(isopropylsulfonyl)cyclopentyl)-3-oxomorpholin-2-yl)acetic acid; or 2-((2S,5R,6R)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((1R,2R)-2-(isopropylsulfonyl)cyclopentyl)-3-oxomorpholin-2-yl)acetic acid.
地址 Thousand Oaks CA US